Home › Free Stock Grades › TGTX
TG Therapeutics, Inc. (TGTX) Stock Grade
TGTX · Healthcare
A+
Market Cap
$4.3B
P/E Ratio
9.6
Revenue Growth (YoY)
+87.3%
Net Margin
72.6%
Return on Equity
69.0%
Dividend Yield
None
About TG Therapeutics, Inc.'s fundamentals
TG Therapeutics is a biotechnology company with a $4.3 billion market capitalization showing strong financial momentum, with revenue growing 87.3% year-over-year and an exceptionally high net profit margin of 72.6%. The company generates a return on equity of 69.0%, indicating efficient capital deployment, while trading at a P/E ratio of 9.6 relative to its earnings. The company does not currently pay a dividend, suggesting profits are being reinvested into operations or research and development activities.